One-year COVID-19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross-sectional comprehensive study (ONCOCARE-COV).
Fiche publication
Date publication
mai 2022
Journal
Cancer medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier, Dr DALSTEIN Véronique, Dr GARBAR Christian, Pr MERROUCHE Yacine, Dr BOULAGNON-ROMBI Camille, Dr DEBREUVE-THERESETTE Adeline
Tous les auteurs :
Laurent L, Brugel M, Carlier C, Clere F, Bertrand A, Botsen D, Boulagnon-Rombi C, Dalstein V, Debreuve-Theresette A, Deguelte S, Garbar C, Mahmoudi R, Marechal A, Morland D, Rey JB, Schvartz C, Vallet C, Merrouche Y, Slimano F, Bouché O
Lien Pubmed
Résumé
The COVID-19 pandemic led to a widely documented disruption in cancer care pathway. Since a resurgence of the pandemic was expected after the first lockdown in France, the global impact on the cancer care pathway over the year 2020 was investigated.
Mots clés
COVID-19 pandemic, backlog, cancer care pathway, lockdowns
Référence
Cancer Med. 2022 05 20;: